QCOM names ML expert Jeremy Kolter to board with 1,049 DSUs
Rhea-AI Filing Summary
QUALCOMM Incorporated added Dr. Jeremy (Zico) Kolter to its Board of Directors on September 2, 2025. Dr. Kolter, a professor and department head in machine learning at Carnegie Mellon University, was appointed for a term expiring at the next annual stockholders meeting and assigned to the Governance Committee. The company states there are no arrangements or reportable transactions between Dr. Kolter and the company. Under the 2025 Director Compensation Plan, Dr. Kolter received 1,049 deferred stock units (DSUs) as a pro rata award for his partial-year service; compensation details for the plan are described in Exhibit 10.21 for the fiscal year ended September 29, 2024.
Positive
- Board expertise: Addition of a leading machine learning academic (Dr. Jeremy Kolter) to the Board
- Committee assignment: Immediate appointment to the Governance Committee, strengthening oversight capabilities
- Alignment of interests: Grant of 1,049 DSUs under the Director Compensation Plan aligns new director with shareholders
Negative
- None.
Insights
New board member with deep ML expertise strengthens board oversight on AI strategy.
The appointment of Dr. Jeremy Kolter brings a senior academic in machine learning to the board and places him on the Governance Committee, which can influence oversight of strategy and risk related to AI and product direction. The term runs until the next annual meeting, giving shareholders a near-term opportunity to approve his election.
Compensation via 1,049 DSUs aligns his interests with long-term shareholder value while following the stated Director Compensation Plan; monitor any future disclosures linking committee work to AI-related programs or material strategy shifts over the next 12 months.
Grant is a standard pro rata DSU award under the disclosed director plan.
The filing confirms there are no reportable Item 404 transactions and that Dr. Kolter will be paid under the existing 2025 Director Compensation Plan, referenced to Exhibit 10.21 of the fiscal 2024 filings. The grant of 1,049 DSUs represents a pro rata portion of a full-year award for a non-employee director.
Investors should watch for the next proxy or amendment showing full-year director pay levels and any board committee shifts; any future material transactions involving Dr. Kolter would require additional disclosure.